TY - JOUR
T1 - Effects of diabetes and cadaveric organs on functional performance and health-related quality of life after kidney transplantation
AU - Kizilisik, A. Tarik
AU - Feurer, Irene D.
AU - VanBuren, David H.
AU - Wise, Paul
AU - Van Buren, Denise
AU - Hopkins, Jeanne
AU - Ray, Jackie
AU - Nylander, William
AU - Shaffer, David
AU - Helderman, J. Harold
AU - Langone, Anthony J.
AU - Speroff, Theodore
AU - Pinson, C. Wright
N1 - Funding Information:
Supported by a grant from Roche Laboratories, Inc.
PY - 2003/11
Y1 - 2003/11
N2 - Background: The current study was undertaken to identify factors specific to kidney transplantation that are associated with posttransplant functional performance (FP) and health-related quality of life (HRQOL). Methods: Karnofsky FP status was assessed longitudinally in 86 adult kidney transplant recipients. Patients reported HRQOL using the Short Form-36 (SF-36) health survey and the Psychosocial Adjustment to Illness Scale (PAIS). Results: FP improved (P <0.001) after kidney transplantation (from 75 ± 1 to 77 ± 1, 81 ± 1, and 82 ± 1 at 0, 3, 6, and 12 months, respectively). Patients receiving organs from living donors showed continued improvement through posttransplant year 1 while those receiving cadaveric organs stabilized at month 6 (simple interaction contrast, year 1 versus pretransplant; P <0.05). Patients receiving dialysis therapy for 6 months or more prior to transplantation demonstrated lower SF-36 posttransplant physical component scores in comparison with patients who were transplanted preemptively (38 ± 1 versus 45 ± 2, P <0.05). Path analysis demonstrated the positive direct effect of time on FP with kidney transplantation (β = 0.23, P <0.05), and the negative direct effects on FP of diabetes (β = -0.22) and cadaveric organs (β = -0.22, both P <0.05). In turn, FP had a positive direct effect on HRQOL (β = 0.40, P <0.001). Conclusions: Overall improvement in FP is attenuated 1 year after kidney transplantation in recipients of organs from cadaveric donors. The positive effect of time after transplantation, and the negative effects of cadaveric organs and diabetes on posttransplant HRQOL, are indirect and are mediated by the direct effects of these variables on posttransplant FP.
AB - Background: The current study was undertaken to identify factors specific to kidney transplantation that are associated with posttransplant functional performance (FP) and health-related quality of life (HRQOL). Methods: Karnofsky FP status was assessed longitudinally in 86 adult kidney transplant recipients. Patients reported HRQOL using the Short Form-36 (SF-36) health survey and the Psychosocial Adjustment to Illness Scale (PAIS). Results: FP improved (P <0.001) after kidney transplantation (from 75 ± 1 to 77 ± 1, 81 ± 1, and 82 ± 1 at 0, 3, 6, and 12 months, respectively). Patients receiving organs from living donors showed continued improvement through posttransplant year 1 while those receiving cadaveric organs stabilized at month 6 (simple interaction contrast, year 1 versus pretransplant; P <0.05). Patients receiving dialysis therapy for 6 months or more prior to transplantation demonstrated lower SF-36 posttransplant physical component scores in comparison with patients who were transplanted preemptively (38 ± 1 versus 45 ± 2, P <0.05). Path analysis demonstrated the positive direct effect of time on FP with kidney transplantation (β = 0.23, P <0.05), and the negative direct effects on FP of diabetes (β = -0.22) and cadaveric organs (β = -0.22, both P <0.05). In turn, FP had a positive direct effect on HRQOL (β = 0.40, P <0.001). Conclusions: Overall improvement in FP is attenuated 1 year after kidney transplantation in recipients of organs from cadaveric donors. The positive effect of time after transplantation, and the negative effects of cadaveric organs and diabetes on posttransplant HRQOL, are indirect and are mediated by the direct effects of these variables on posttransplant FP.
KW - Diabetes
KW - Kidney transplant
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=0242266599&partnerID=8YFLogxK
U2 - 10.1016/j.amjsurg.2003.07.013
DO - 10.1016/j.amjsurg.2003.07.013
M3 - Article
C2 - 14599621
AN - SCOPUS:0242266599
SN - 0002-9610
VL - 186
SP - 535
EP - 539
JO - American journal of surgery
JF - American journal of surgery
IS - 5
ER -